Subject of the day
WAT
Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. The company operates through two segments, Waters and TA. The company designs, manufactures, sells, and services liquid chromatography, as well as mass spectrometry (MS) technology systems and supports products, including chromatography columns, and other consumable products. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer goods, and healthcare products, as well as for life science research; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. In addition, the company offers MS technology, which is used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. Its products are used by clinical, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. The company was founded in 1958 and is headquartered in Milford, Massachusetts.
FY 2009–2025 · 17 years
| Line | Latest | CAGR | Trend |
|---|---|---|---|
| Revenue | $636.84M | -5.2% | |
| Gross profit | $242.79M | -19.7% | |
| Operating income | $817.68M | +5.5% | |
| Net income | $642.23M | -9.3% | |
| Cash from ops | $652.55M | +3.8% |
$413.51
▼ -2.64 (-0.6%)
| 52w hi | $416.15 |
|---|---|
| 52w lo | $283.32 |
| Vol | 557.35K |
| As of | Aug 13 |
Our score +0.40
| Short | +0.25 |
|---|---|
| Medium | +0.53 |
| Long | +0.43 |
computed 2026-08-13
Waters Corporation
Healthcare · Diagnostics & Research
| Market cap | $40.60B |
|---|---|
| Enterprise value | $45.82B |
| Trailing P/E | 104.69x |
| Forward P/E | 24.97x |
| EV / EBITDA | 31.56x |
| P / S (ttm) | 8.74x |
| Profit margin | 3.6% |
| Return on equity | 1.9% |
| Revenue growth | +113.4% |
| Earnings growth | — |
| Debt / equity | 36.05 |
| Beta vs SPX | 0.95 |
|---|---|
| Corr SPX | 0.41 |
| Annual vol | 38.0% |
| Annual ret | +17.9% |
| Sharpe | 0.47 |
| Max DD | -33.4% |
Window: 504 trading days (504 obs)
| Layer | Raw | Contribution |
|---|---|---|
| Fundamental | +0.25 | |
| Sector | +0.12 | |
| Technical | +0.22 | |
| Earnings | +0.00 | |
| Sentiment | +0.00 |
macro × 1.00 · 2026-08-13
| Date | Open | High | Low | Close | Vol |
|---|---|---|---|---|---|
| Aug 13 | $412.63 | $420.25 | $408.81 | $413.51 | 557.35K |
| Aug 12 | $404.77 | $416.62 | $404.77 | $416.15 | 736.90K |
| Aug 11 | $408.95 | $415.63 | $408.21 | $415.00 | 669.80K |
| Aug 10 | $405.77 | $413.34 | $402.63 | $411.77 | 826.60K |
| Aug 7 | $400.60 | $407.88 | $397.09 | $406.86 | 888.60K |